Changes in the soluble mucosal immune environment during genital herpes outbreaks

Marla J. Keller, Rebecca P. Madan, Gail Shust, Colleen A. Carpenter, N. Merna Torres, Sylvia Cho, Hnin Khine, Meei Li Huang, Lawrence Corey, Mimi Kim, Betsy Herold

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

BACKGROUND: Genital tract secretions provide variable inhibitory activity against herpes simplex virus (HSV) ex vivo. We hypothesize that the anti-HSV activity may prevent the spread of virus from the more commonly affected sites, such as the external genitalia, to the upper genital tract. METHODS: The antimicrobial activity of cervicovaginal lavage (CVL) and concentrations of mucosal immune mediators were measured in 10 HIV-seronegative women with an active external herpetic lesion and compared with 10 HIV-seronegative women who were HSV-1 and HSV-2 seronegative. Samples were obtained at the time of a symptomatic external lesion (day 0), after 1 week of oral acyclovir (day 7), and 1 week after completing treatment (day 14). Controls were evaluated at parallel intervals. RESULTS: The anti-HSV activity was higher in CVL obtained from cases compared to controls at presentation (day 0) (54.3% vs. 28%), fell to similar levels on day 7, and then rebounded on day 14 (69% vs. 25%). The anti-HSV activity correlated positively and significantly with the concentrations of several inflammatory proteins; the concentrations of these proteins tended to be higher in cases compared with controls and followed a similar temporal pattern. CONCLUSIONS: Increases in inflammatory immune mediators and anti-HSV activity were detected in CVL at the time of clinical outbreaks and after completion of a short course of acyclovir. These mucosal responses may protect against HSV spread but could facilitate HIV infection and contribute to the clinical observation that, independent of clinical lesions, HSV-2 is a risk factor for HIV acquisition.

Original languageEnglish (US)
Pages (from-to)194-202
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes
Volume61
Issue number2
DOIs
StatePublished - Oct 1 2012

Fingerprint

Herpes Genitalis
Simplexvirus
Disease Outbreaks
Therapeutic Irrigation
Human Herpesvirus 2
Acyclovir
HIV
Genitalia
Human Herpesvirus 1
HIV Infections
Proteins
Viruses

Keywords

  • herpes simplex virus
  • human immunodeficiency virus
  • soluble mucosal immunity

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Changes in the soluble mucosal immune environment during genital herpes outbreaks. / Keller, Marla J.; Madan, Rebecca P.; Shust, Gail; Carpenter, Colleen A.; Torres, N. Merna; Cho, Sylvia; Khine, Hnin; Huang, Meei Li; Corey, Lawrence; Kim, Mimi; Herold, Betsy.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 61, No. 2, 01.10.2012, p. 194-202.

Research output: Contribution to journalArticle

Keller, Marla J. ; Madan, Rebecca P. ; Shust, Gail ; Carpenter, Colleen A. ; Torres, N. Merna ; Cho, Sylvia ; Khine, Hnin ; Huang, Meei Li ; Corey, Lawrence ; Kim, Mimi ; Herold, Betsy. / Changes in the soluble mucosal immune environment during genital herpes outbreaks. In: Journal of Acquired Immune Deficiency Syndromes. 2012 ; Vol. 61, No. 2. pp. 194-202.
@article{32a89ae8adb545ffb33ccc7faba5ab7d,
title = "Changes in the soluble mucosal immune environment during genital herpes outbreaks",
abstract = "BACKGROUND: Genital tract secretions provide variable inhibitory activity against herpes simplex virus (HSV) ex vivo. We hypothesize that the anti-HSV activity may prevent the spread of virus from the more commonly affected sites, such as the external genitalia, to the upper genital tract. METHODS: The antimicrobial activity of cervicovaginal lavage (CVL) and concentrations of mucosal immune mediators were measured in 10 HIV-seronegative women with an active external herpetic lesion and compared with 10 HIV-seronegative women who were HSV-1 and HSV-2 seronegative. Samples were obtained at the time of a symptomatic external lesion (day 0), after 1 week of oral acyclovir (day 7), and 1 week after completing treatment (day 14). Controls were evaluated at parallel intervals. RESULTS: The anti-HSV activity was higher in CVL obtained from cases compared to controls at presentation (day 0) (54.3{\%} vs. 28{\%}), fell to similar levels on day 7, and then rebounded on day 14 (69{\%} vs. 25{\%}). The anti-HSV activity correlated positively and significantly with the concentrations of several inflammatory proteins; the concentrations of these proteins tended to be higher in cases compared with controls and followed a similar temporal pattern. CONCLUSIONS: Increases in inflammatory immune mediators and anti-HSV activity were detected in CVL at the time of clinical outbreaks and after completion of a short course of acyclovir. These mucosal responses may protect against HSV spread but could facilitate HIV infection and contribute to the clinical observation that, independent of clinical lesions, HSV-2 is a risk factor for HIV acquisition.",
keywords = "herpes simplex virus, human immunodeficiency virus, soluble mucosal immunity",
author = "Keller, {Marla J.} and Madan, {Rebecca P.} and Gail Shust and Carpenter, {Colleen A.} and Torres, {N. Merna} and Sylvia Cho and Hnin Khine and Huang, {Meei Li} and Lawrence Corey and Mimi Kim and Betsy Herold",
year = "2012",
month = "10",
day = "1",
doi = "10.1097/QAI.0b013e31826867ae",
language = "English (US)",
volume = "61",
pages = "194--202",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Changes in the soluble mucosal immune environment during genital herpes outbreaks

AU - Keller, Marla J.

AU - Madan, Rebecca P.

AU - Shust, Gail

AU - Carpenter, Colleen A.

AU - Torres, N. Merna

AU - Cho, Sylvia

AU - Khine, Hnin

AU - Huang, Meei Li

AU - Corey, Lawrence

AU - Kim, Mimi

AU - Herold, Betsy

PY - 2012/10/1

Y1 - 2012/10/1

N2 - BACKGROUND: Genital tract secretions provide variable inhibitory activity against herpes simplex virus (HSV) ex vivo. We hypothesize that the anti-HSV activity may prevent the spread of virus from the more commonly affected sites, such as the external genitalia, to the upper genital tract. METHODS: The antimicrobial activity of cervicovaginal lavage (CVL) and concentrations of mucosal immune mediators were measured in 10 HIV-seronegative women with an active external herpetic lesion and compared with 10 HIV-seronegative women who were HSV-1 and HSV-2 seronegative. Samples were obtained at the time of a symptomatic external lesion (day 0), after 1 week of oral acyclovir (day 7), and 1 week after completing treatment (day 14). Controls were evaluated at parallel intervals. RESULTS: The anti-HSV activity was higher in CVL obtained from cases compared to controls at presentation (day 0) (54.3% vs. 28%), fell to similar levels on day 7, and then rebounded on day 14 (69% vs. 25%). The anti-HSV activity correlated positively and significantly with the concentrations of several inflammatory proteins; the concentrations of these proteins tended to be higher in cases compared with controls and followed a similar temporal pattern. CONCLUSIONS: Increases in inflammatory immune mediators and anti-HSV activity were detected in CVL at the time of clinical outbreaks and after completion of a short course of acyclovir. These mucosal responses may protect against HSV spread but could facilitate HIV infection and contribute to the clinical observation that, independent of clinical lesions, HSV-2 is a risk factor for HIV acquisition.

AB - BACKGROUND: Genital tract secretions provide variable inhibitory activity against herpes simplex virus (HSV) ex vivo. We hypothesize that the anti-HSV activity may prevent the spread of virus from the more commonly affected sites, such as the external genitalia, to the upper genital tract. METHODS: The antimicrobial activity of cervicovaginal lavage (CVL) and concentrations of mucosal immune mediators were measured in 10 HIV-seronegative women with an active external herpetic lesion and compared with 10 HIV-seronegative women who were HSV-1 and HSV-2 seronegative. Samples were obtained at the time of a symptomatic external lesion (day 0), after 1 week of oral acyclovir (day 7), and 1 week after completing treatment (day 14). Controls were evaluated at parallel intervals. RESULTS: The anti-HSV activity was higher in CVL obtained from cases compared to controls at presentation (day 0) (54.3% vs. 28%), fell to similar levels on day 7, and then rebounded on day 14 (69% vs. 25%). The anti-HSV activity correlated positively and significantly with the concentrations of several inflammatory proteins; the concentrations of these proteins tended to be higher in cases compared with controls and followed a similar temporal pattern. CONCLUSIONS: Increases in inflammatory immune mediators and anti-HSV activity were detected in CVL at the time of clinical outbreaks and after completion of a short course of acyclovir. These mucosal responses may protect against HSV spread but could facilitate HIV infection and contribute to the clinical observation that, independent of clinical lesions, HSV-2 is a risk factor for HIV acquisition.

KW - herpes simplex virus

KW - human immunodeficiency virus

KW - soluble mucosal immunity

UR - http://www.scopus.com/inward/record.url?scp=84866994975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866994975&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e31826867ae

DO - 10.1097/QAI.0b013e31826867ae

M3 - Article

C2 - 22820806

AN - SCOPUS:84866994975

VL - 61

SP - 194

EP - 202

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 2

ER -